What is the recommended dosing regimen for Ristela (L‑arginine supplement)?

Ristela Dosing

Ristela (risperidone) is not an L-arginine supplement—it is an antipsychotic medication with specific dosing regimens that vary by indication, age, and patient characteristics. The FDA-approved dosing must be followed precisely to balance efficacy and safety 1.

Dosing by Indication

Schizophrenia in Adults

• Initial dose: 2 mg per day (once or twice daily) 1
• Titration: Increase at intervals of ≥24 hours in increments of 1-2 mg/day as tolerated 1
• Target dose: 4-8 mg per day 1
• Effective range: 4-16 mg per day, though doses above 6 mg/day for twice-daily dosing showed no additional efficacy and increased extrapyramidal symptoms 1
• Maximum studied dose: 16 mg per day 1

Schizophrenia in Adolescents

• Initial dose: 0.5 mg once daily (morning or evening) 1
• Titration: Increase at intervals of ≥24 hours in increments of 0.5-1 mg/day as tolerated 1
• Target dose: 3 mg per day 1
• Effective range: 1-6 mg per day, though no additional benefit was observed above 3 mg/day 1
• Note: Patients with persistent somnolence may benefit from splitting the daily dose into twice-daily administration 1

Bipolar Mania in Adults

• Initial dose: 2-3 mg per day 1
• Titration: Increase at intervals of ≥24 hours in increments of 1 mg/day 1
• Effective range: 1-6 mg per day 1
• Note: Doses higher than 6 mg/day have not been studied 1

Bipolar Mania in Pediatrics

• Initial dose: 0.5 mg once daily (morning or evening) 1
• Titration: Increase at intervals of ≥24 hours in increments of 0.5-1 mg/day as tolerated 1
• Target dose: 1-2.5 mg per day 1
• Effective range: 0.5-6 mg per day, though no additional benefit was observed above 2.5 mg/day 1
• Note: Patients with persistent somnolence may benefit from twice-daily dosing 1

Irritability Associated with Autistic Disorder (Pediatrics)

Dosing is weight-based: 1

For patients <20 kg:

• Initial dose: 0.25 mg per day 1
• Day 4 increase: May increase to 0.5 mg per day 1
• Further titration: After ≥14 days at 0.5 mg/day, may increase in 0.25 mg increments at intervals of ≥2 weeks 1
• Target dose: 0.5 mg per day 1
• Effective range: 0.5-3 mg per day 1

For patients ≥20 kg:

• Initial dose: 0.5 mg per day 1
• Day 4 increase: May increase to 1 mg per day 1
• Further titration: After ≥14 days at 1 mg/day, may increase in 0.5 mg increments at intervals of ≥2 weeks 1
• Target dose: 1 mg per day 1
• Effective range: 0.5-3 mg per day 1

Note: No dosing data available for children weighing <15 kg 1

Special Population Adjustments

Severe Renal or Hepatic Impairment

• Initial dose: 0.5 mg twice daily 1
• Titration: Increase in increments of ≤0.5 mg, administered twice daily 1
• For doses >1.5 mg twice daily: Increase at intervals of ≥1 week 1
• Applies to: Severe renal impairment (CrCl <30 mL/min) or hepatic impairment (Child-Pugh 10-15 points) 1

Drug Interaction Adjustments

With enzyme inducers (carbamazepine, phenytoin, rifampin, phenobarbital):

• Increase risperidone dose up to double the usual dose 1
• Decrease dose when enzyme inducers are discontinued 1

With enzyme inhibitors (fluoxetine, paroxetine):

• Reduce risperidone dose 1
• Maximum dose: 8 mg per day in adults when coadministered with these drugs 1
• Titrate slowly when initiating therapy 1
• Increase dose when enzyme inhibitors are discontinued 1

Administration Considerations

• Dosing frequency: Can be administered once daily or twice daily depending on indication and tolerability 1
• Somnolence management: Patients experiencing persistent somnolence may benefit from bedtime dosing, twice-daily split dosing, or dose reduction 1
• Maintenance therapy: Periodically reassess the need for continued treatment 1

Critical Pitfall

Do not confuse Ristela (risperidone) with L-arginine supplements. The evidence provided includes research on L-arginine for cardiovascular conditions 2, 3, 4, 5, 6, but these are entirely different substances with different indications. Risperidone is a psychiatric medication requiring careful dose titration and monitoring for extrapyramidal symptoms and metabolic effects 1.